Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Jul 23, 2015"Our strong performance in the second quarter reflects the consistent execution of our global teams," said Mike Mahoney, CEO of Boston Scientific.
Jul 22, 2015First Guidewire Designed Specifically for TAVI/R Now Sized for Smaller VentriclesFirst guidewire designed specifically for TAVI/R now sized for smaller ventricles
Jul 20, 2015First Patients Enrolled in the FAST Feasibility StudyFirst Patients Enrolled in the FAST Feasibility Study
Jul 15, 2015Chairman Pete Nicholas welcomes James as a business leader with “significant financial knowledge, HR management and organizational planning skills.”
Jul 9, 2015Demonstrates growing clinical acceptance for novel, procedure-based treatment option for severe asthma
- Jul 1, 2015
Boston Scientific will webcast its conference call with financial results and business highlights for Q2 ending June 15, 2015. Learn how to tune in.
Jun 22, 2015Study to evaluate patients implanted with S-ICD for primary prevention of sudden cardiac death in the setting of severely reduced cardiac function
Jun 10, 2015Spinal cord stimulator (SCS) system provided 1.5x better overall pain relief and 2x better low back pain relief than previous generation system
Jun 4, 2015World's Smallest 16-Contact High-Capacity Primary Cell Device Expands Spinal Cord Stimulator System OfferingWorld's smallest 16-contact high-capacity primary cell device expands spinal cord stimulator system (SCS) offering
May 26, 2015Boston Scientific will participate in the healthcare conference on June 9, 2015. Learn how to watch the webcast or replay.
May 20, 2015Compelling Results Presented at EuroPCR 2015 Add to Growing Body of Evidence Supporting Performance and SafetyCompelling results presented at EuroPCR 2015 add to growing body of evidence supporting performance and safety
May 19, 2015Additional Data from EVOLVE II Pivotal Trial Demonstrate Safety and Performance in Patients with Diabetes at One YearAdditional data from EVOLVE II pivotal trial demonstrate safety and performance in patients with diabetes at one year
May 12, 2015Boston Scientific Corporation (NYSE: BSX) announced its completed public offering of senior notes
May 11, 2015Key data from 42 abstracts to include presentations on the WATCHMAN device and the EMBLEM S-ICD system.
- May 7, 2015
Boston Scientific Corporation (NYSE: BSX) announced its pricing of a public offering of senior notes
May 6, 2015Recognition From Shingo Institute is the Second in Two Years for a Company FacilityRecognition from Shingo Institute is the second in two years for a company facility
- May 1, 2015
CEO Mike Mahoney will outline company's unique opportunities to bring forward meaningful innovation
- Apr 30, 2015Customized Programs to Drive Operational and Care Pathway Improvements
Customized programs to drive operational and care pathway improvements
- Apr 28, 2015
"We achieved strong results in the first quarter and continue to build global momentum," said CEO Mike Mahoney
Apr 28, 2015MAJESTIC Trial Meets Performance Endpoint With Compelling ResultsMAJESTIC trial meets performance endpoint with compelling results
Apr 27, 2015Boston Scientific will participate in an upcoming healthcare conference on May 12, 2015. A live webcast and replay will be available.
Apr 27, 2015Collaboration provides patients and physicians a comprehensive portfolio for Deep Brain Stimulation (DBS) therapy
- Apr 24, 2015
Boston Scientific will participate in an upcoming healthcare conference on May 6, 2015. A live webcast and replay will be available.
Apr 20, 2015Results Published in the Journal of American College of CardiologyResults published in the Journal of American College of Cardiology
Apr 16, 2015Boston Scientific Corporation (NYSE: BSX) is taking a new approach to evaluate the performance of the Vessix™ Renal Denervation System, initiating a study with a novel design to isolate the...